Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs

  • 📰 CNBC
  • ⏱ Reading Time:
  • 9 sec. here
  • 15 min. at publisher
  • 📊 Quality Score:
  • News: 52%
  • Publisher: 72%

Dividends Nieuws

United States,Pfizer Inc,Spin-Offs

The results come as Pfizer scrambles to stabilize its business and win back Wall Street’s favor following the rapid decline in demand for its Covid products.

Pfizer reported second-quarter revenue and adjusted earnings that blew past expectations and raised its full-year outlook as the drugmaker works to slash costs.

Pfizer also hiked its revenue outlook to a range of $59.5 billion to $62.5 billion, up from a previous revenue forecast of between $58.5 billion and $61.5 billion.

Wij hebben dit nieuws samengevat zodat u het snel kunt lezen. Bent u geïnteresseerd in het nieuws, dan kunt u hier de volledige tekst lezen. Lees verder:

 /  🏆 12. in NL
 

Bedankt voor uw reactie. Uw reactie wordt na beoordeling gepubliceerd.

Nederland Laatste Nieuws, Nederland Headlines